RefBan

Referral Banners

Yashi

Wednesday, June 18, 2014

Reuters Health Report

Click to View in Browser
06/18/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Big Tobacco squares up as EU rules aim to track every cigarette
BAYREUTH Germany (Reuters) - It takes a British American Tobacco factory machine three minutes to load 4 million cigarettes onto a truck in northern Bavaria - but it can take a lot longer to figure out whether those cigarettes end up where they should.
Air pollution linked to cognitive decline in later years
NEW YORK (Reuters Health) - The tiny particles in vehicle exhaust and other sources of air pollution may hasten cognitive decline in older adults, according to a new U. S. study.
Food firms seek to rebuild trust with labeling, ad pledge
PARIS (Reuters) - The world's top food and drink companies announced a raft of measures on Wednesday to try to improve the industry's image, including stopping advertising junk food to children by 2018, harmonizing nutritional labeling and fighting deforestation.
U.S. government confident new vaccine will help fight pig virus
PARIS (Reuters) - U.S. Agriculture Secretary Tom Vilsack said on Wednesday he was confident a vaccine approved this week by the U.S. administration would help fight a deadly virus which has killed millions of pigs in the United States.
Death toll from West Africa Ebola hits 337: WHO update
DAKAR (Reuters) - The death toll from an outbreak of Ebola in Guinea, Liberia and Sierra Leone has hit 337 since February, the U.N. World Health Organisation said on Wednesday, as weak local health services struggle to contain the highly contagious disease.
Novartis says slimmer structure to boost profitability
ZURICH (Reuters) - Novartis AG on Wednesday shed some light on how an overhaul of its business could boost profitability even in a "brutal" era for health spending, saying the shake-up would have lifted core operating margins by 2.5 percentage points last year.
French biotech Cellectis surges as Pfizer signs cancer drug deal
(Reuters) - U.S. drugmaker Pfizer, which failed last month in a $118 billion bid to buy AstraZeneca, said on Wednesday it had signed a deal with French biotech Cellectis to develop immunotherapy drugs in cancer.
Novartis, Pfizer seek U.S. approval of meningitis vaccines
(Reuters) - Pfizer Inc and rival Swiss drugmaker Novartis AG on Tuesday said they had asked U.S. regulators to approve their vaccines to prevent meningitis infections in people aged 10 to 25.
Could ignorance of illness be better for mental health?
NEW YORK (Reuters Health) - People who don't know they have health problems rate their own health as good, according to a new study, but their self-image worsens when they're aware of their diagnosis.
Senate panel scolds TV's Dr. Oz over diet claims
WASHINGTON (Reuters) - A U.S. Senate panel probing bogus diet product ads took celebrity doctor Mehmet Oz to task on Tuesday for touting weight-loss products on his syndicated television show.
Related Video
Crippled dog gets new lease on life
Twin tornadoes pummel U.S. state of Nebraska, killing one
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika